MNA Webinar Series - Fall 2024
---
ABOUT:
Join us for an enlightening three-part webinar series. This series will start off featuring expert presentations from the National MS Society and the Epilepsy Foundation. These sessions will dive deep into the resources and advocacy efforts available to those affected by multiple sclerosis and epilepsy. Our third session will be an CME educational webinar titled "Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea".
Discover valuable tools, gain insights from industry leaders, and learn how you can make a difference.
This webinar series is FREE of registration fees.
There will be time dedicated for Q&As. You can submit your questions in advanced via email to mna@mms.org or during the webinar through the chat.
---
WHEN:
#1: Tuesday, Oct 15, 2024 (7:00-8:00 PM)
#2: Tuesday, Oct 22, 2024 (7:00-8:00 PM)
#3: Tuesday, Oct 29, 2024 (7:00-8:00 PM)
---
WHERE:
Online via Zoom
---
SESSIONS:
#1 (OCT 15) - Policy, Advocacy, and Support Services for People Living with Epilepsy
Susan Linn, President & CEO, Epilepsy Foundation of New England
Bill Murphy, Director of Advocacy and Public Policy, Epilepsy Foundation of New England
EFNE provides a wide array of free services to meet people living with epilepsy at all points along their journey living with epilepsy- from daily support check-ins to one-time “helpdesk” Q&A. Join us to learn how the EFNE team can support your team and your patients. What political advocacy issues are facing the epilepsy community? How might you get involved? Are their support services missing from our landscape? Please come share your thoughts to shape future services.
#2 (OCT 22) - Introduction to the National Multiple Sclerosis Society’s Resources
Shanna McCabe, Manager, National Multiple Sclerosis Society
The National Multiple Sclerosis Society is pleased to offer a webinar for members of the Massachusetts Neurological Association. During this interactive session, attendees will learn about the Society’s mission, services and programs available to people living with Multiple Sclerosis, and resources for healthcare providers and their practice. Attendees will have the chance to ask questions and discover how the Society can be a valuable partner in caring for their patients with Multiple Sclerosis.
#3 (OCT 29) - Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea
Register: clinicaloptions.com/2024MNAChapter
1.0 AMA PRA Category 1 CreditTM; ABP MOC
Victor W. Sung, MD, Professor of Neurology, University of Alabama at Birmingham
This activity will improve the knowledge, competence, and performance of learners to optimize treatment for patients with Huntington’s disease (HD).
Learning Objectives:
Upon completion of this activity, learners should be able to:
· Identify strategies for improving identification of and management of HD and chorea
· Incorporate communication strategies and shared decision-making into care plans to address the impact of chorea on patients and caregivers
· Assess evidence for efficacy and safety profiles of newer agents used in the treatment of HD chorea
· Construct a patient care plan that integrates novel agents into the current treatment of HD chorea
